Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methapyrilene (substance) |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Tripelennamine (substance) |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Antazoline (substance) |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Mepyramine |
Is a |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing ethylenediamine derivative and histamine receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
1 |
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Mepyramine maleate [antihistamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Mepyramine maleate [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing chlorphenamine and mepyramine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing dexbrompheniramine and mepyramine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
pyrilamine maleate+benzocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Product containing benzocaine and mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Antazoline sulfate (substance) |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Antazoline hydrochloride |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Antazoline phosphate (substance) |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Tripelennamine hydrochloride |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|
Tripelennamine citrate |
Is a |
True |
Ethylenediamine derivative antihistamine |
Inferred relationship |
Some |
|